Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 2 institutions in 1 country.
Remedios Gómez-SanzDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, 28805 Madrid, Spain.
Enrique Ovejero-MerinoDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, 28805 Madrid, Spain.ORCID 0000-0002-4254-3594
Inmaculada Lasa-UnzúeDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, 28805 Madrid, Spain.
Adela López-GarcíaDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, 28805 Madrid, Spain.
Ruth Marcos-HernándezDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, 28805 Madrid, Spain.
Javier Mínguez-GarcíaDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, 28805 Madrid, Spain.
Francisca García-Moreno NisaDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, 28805 Madrid, Spain.ORCID 0000-0001-5360-0577
Fernando Mendoza-MorenoDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, 28805 Madrid, Spain.ORCID 0000-0002-1046-6344
Manuel Díez-AlonsoDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, 28805 Madrid, Spain.
Miguel A OrtegaDepartment of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, 28801 Alcalá de Henares, Spain.ORCID 0000-0003-2588-1708
Melchor Álvarez-MonDepartment of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, 28801 Alcalá de Henares, Spain.ORCID 0000-0003-1309-7510
Alberto Gutiérrez-CalvoDepartment of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, 28805 Madrid, Spain.
The Spanish Prs Collaborating Group
Hospital Universitario Príncipe de Asturias · ESUniversidad de Alcalá · ES
Funding
Comunidad de Madrid MITIC-CM
6 · The paper itself
Abstract
introductionHyperthermic IntraPEritoneal Chemotherapy (HIPEC) has evolved as a treatment for peritoneal carcinomatosis in various tumors after a careful and complete cytoreductive surgery, and it demonstrated much better and longer survival than more traditional therapeutic schemas. Our objective has been to examine the safety, efficacy and survival achieved with closed technique with CO
Indexed as
cytoreductive surgeryintraoperative intraperitoneal chemotherapyintraperitoneal chemotherapyperitoneal carcinomatosisSpanish PRS Group
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Hyperthermic Intraperitoneal Chemotherapy and Recirculation with CO · full record | OpenQuestion